Related Experiment Videos

Why Mild Cognitive Impairment Should Not Be Approached as a Disease: Reply to Iraqi and Hughes

Marco Canevelli¹, Giulia Grande², Eleonora Lacorte³

¹Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy.

Journal of the American Medical Directors Association

|February 27, 2017

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Sociodemographic and clinical characteristics of participants in blood p-tau217 studies for Alzheimer's disease: A systematic review.

Ageing research reviews·2026

Integrating frailty into decision-making for disease-modifying therapies in Alzheimer's disease: a proposed expert-opinion based approach.

The journal of prevention of Alzheimer's disease·2026

Blood Biomarkers of Alzheimer's Disease and Gait Speed Trajectories in Community-Dwelling Older Adults: A Cohort Study.

Journal of cachexia, sarcopenia and muscle·2026

Blood Biomarkers of Alzheimer Disease and Rates of Global and Domain-Specific Cognitive Decline.

JAMA network open·2026

Blood Biomarkers of Alzheimer's Disease and Patterns of Structural Brain Changes in the Community.

Annals of neurology·2026

The role of disadvantaged childhood conditions on cognitive function and disability in late life: findings from a Swedish longitudinal study.

Journal of clinical and experimental neuropsychology·2026

See all related articles